PubRank

M B Chancellor

Author PubWeight™ 83.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Noninvasive urodynamic evaluation of bladder outlet obstruction using Doppler ultrasonography. Urology 2000 1.54
2 Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 2001 1.54
3 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008 1.45
4 Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol 1999 1.41
5 The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003 1.32
6 Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 1999 1.32
7 Bladder and sphincter behavior in patients with spinal cord lesions. J Urol 1991 1.28
8 Urodynamics of spinal cord injury. Urol Clin North Am 1996 1.25
9 The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 2001 1.19
10 Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001 1.18
11 Neural control of the urethra. Scand J Urol Nephrol Suppl 2001 1.17
12 Development of noninvasive velocity flow video urodynamics using Doppler sonography. Part II: clinical application in bladder outlet obstruction. J Urol 1998 1.16
13 The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain. J Neurosci 2001 1.11
14 Development of noninvasive velocity flow video urodynamics using Doppler sonography. Part I: Experimental urethra. J Urol 1998 1.11
15 Early predictors of bladder recovery and urodynamics after spinal cord injury. Neurourol Urodyn 1998 1.09
16 Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol 2000 1.06
17 Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 2000 1.05
18 Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 2002 1.04
19 Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin. Am J Physiol Regul Integr Comp Physiol 2001 1.02
20 Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol 2001 1.01
21 Changes in micturition after spinal cord injury in conscious rats. Urology 1999 1.00
22 Molecular marker for development of interstitial cystitis in rat model: isoactin gene expression. J Urol 1997 0.98
23 Myoblast therapy for stress urinary incontinence and bladder dysfunction. World J Urol 2000 0.97
24 Modified Burch colposuspension for stress urinary incontinence in females. Surg Gynecol Obstet 1993 0.95
25 Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. BJU Int 2003 0.95
26 Effects of cigarette smoke components on in vitro chemotaxis of human polymorphonuclear leukocytes. Infect Immun 1977 0.94
27 Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride. Br J Clin Pharmacol 2001 0.93
28 Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology 2001 0.93
29 Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 2000 0.93
30 Influence of glutamate receptor antagonists on micturition in rats with spinal cord injury. Exp Neurol 1999 0.92
31 The effect of urinary tract reconstruction on neurologically impaired women previously treated with an indwelling urethral catheter. J Urol 1996 0.92
32 Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 2001 0.91
33 Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Ther 2009 0.91
34 Injection of skeletal muscle-derived cells into the penis improves erectile function. Int J Impot Res 2005 0.91
35 Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 2001 0.91
36 Muscle-derived cell transplantation and differentiation into lower urinary tract smooth muscle. Urology 2001 0.90
37 Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Ther 2008 0.89
38 Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther 2007 0.89
39 Lyme cystitis and neurogenic bladder dysfunction. Lancet 1992 0.86
40 Reliability of color Doppler ultrasound urodynamics in the evaluation of bladder outlet obstruction. Urology 2000 0.86
41 High incidence of occult neurogenic bladder dysfunction in neurologically intact patients with thoracolumbar spinal injuries. J Urol 1998 0.86
42 Pharmacologic and potential biologic interventions to restore bladder function after spinal cord injury. Curr Opin Neurol 2000 0.85
43 Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng 2001 0.85
44 Spinal cord injury and bladder recovery. Arch Phys Med Rehabil 1996 0.85
45 Complications of Teflon injection for stress urinary incontinence. Neurourol Urodyn 1993 0.83
46 31-Year-old bladder diverticulocutaneous fistula with a giant stone as a complication of pelvic fracture. Tech Urol 2001 0.83
47 Improved quality of life and sexuality with continent urinary diversion in quadriplegic women with umbilical stoma. Arch Phys Med Rehabil 1995 0.83
48 Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-up. Tech Urol 1999 0.83
49 Latex allergy manifested in urological surgery and care of adult spinal cord injured patients. Arch Phys Med Rehabil 1994 0.82
50 Advantages and risks of ileovesicostomy for the management of neuropathic bladder. Urology 1999 0.82
51 The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Urology 1994 0.82
52 A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride. Urology 2001 0.82
53 Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation. Int Urogynecol J Pelvic Floor Dysfunct 2002 0.81
54 Erectile response to topical, intraurethral and intracorporal pharmacotherapy in a rat model of spinal cord injury. J Spinal Cord Med 1995 0.81
55 Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder. J Endourol 2000 0.81
56 Cutaneous ileocystostomy (a bladder chimney) for the treatment of severe neurogenic vesical dysfunction. Paraplegia 1995 0.80
57 Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Mol Urol 2001 0.80
58 Urodynamic monitoring during percutaneous sacral nerve neurostimulation in patients with neurogenic detrusor hyperreflexia. Neurourol Urodyn 2001 0.80
59 Stem cell therapy for urethral sphincter regeneration. Minerva Urol Nefrol 2008 0.80
60 Interstitial Cystitis and Bladder Research: Progress and Future Directions: Highlights of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Interstitial Cystitis Association (ICA) International Research Symposium October 19-20, 2000, Minneapolis, MN. Rev Urol 2001 0.79
61 Neurological manifestations of baclofen withdrawal. J Urol 1993 0.79
62 Autonomic dysreflexia in a rat model spinal cord injury and the effect of pharmacologic agents. Neurourol Urodyn 1995 0.79
63 Urolume stent placement for the treatment of postbrachytherapy bladder outlet obstruction. Urology 2000 0.79
64 Mapping the future for incontinence treatment worldwide: highlights from the first international consultation on incontinence june 28-july 1, 1998, monaco. Rev Urol 1999 0.79
65 Flexible cystoscopy in spinal cord injury. Review article. Paraplegia 1994 0.78
66 Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells. Int Urol Nephrol 2014 0.78
67 Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers. J Spinal Cord Med 1996 0.78
68 Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Ther 2009 0.78
69 Variations in the gingival polymorphonuclear leukocyte migration rate in dogs induced by chemotactic autologous serum and migration inhibitor from tobacco smoke. J Periodontal Res 1977 0.78
70 Detrusor-myoplasty to restore micturition. Lancet 1994 0.78
71 [Pittsburgh experience with botulinum toxin A injection]. Actas Urol Esp 2006 0.77
72 Medical and minimally invasive treatment of urinary incontinence. Rev Urol 1999 0.77
73 Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain. Urology 2001 0.77
74 Evaluation of autologous fat implantation in the rat urinary bladder submucosa. Urology 1998 0.77
75 Effect of intravesical capsaicin and vehicle on bladder integrity control and spinal cord injured rats. J Urol 1998 0.77
76 Gracilis muscle dynamic urethral sphincter myoplasty: rat model experience. J Urol 1996 0.77
77 Urologic manifestation of spinal cord sarcoidosis. J Spinal Cord Med 1996 0.76
78 Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia 1994 0.76
79 Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia. J Spinal Cord Med 1996 0.76
80 Neurovesical dysfunction in postural tachycardia syndrome (POTS). Int Urogynecol J Pelvic Floor Dysfunct 2002 0.76
81 Prospective comparison of external sphincter prosthesis placement and external sphincterotomy in men with spinal cord injury. J Endourol 1994 0.76
82 Neurogenic vesical dysfunction. Urol Clin North Am 1995 0.76
83 Malignant priapism as the initial clinical manifestation of metastatic renal cell carcinoma with invasion of both corpora cavernosum and spongiosum. Int J Impot Res 1998 0.76
84 Bladder autoaugmentation. Tech Urol 1995 0.76
85 Botulinum-A toxin: an exciting new treatment option for prostatic disease. Int J Clin Pract Suppl 2006 0.76
86 Future trends in the treatment of urinary incontinence. Rev Urol 2001 0.76
87 Managing stress incontinence and classifying detrusor instability. Rev Urol 1999 0.75
88 Comparison of Incontinence Risk after Radical Prostatectomy versus Hysterectomy. Rev Urol 2001 0.75
89 What is the best way to treat incontinence: behavioral or drug treatment? Rev Urol 2000 0.75
90 First-line therapy for stress incontinence. Rev Urol 2000 0.75
91 Managing incontinence: the tip of the iceberg. Rev Urol 1999 0.75
92 A Gathering of Urologists and Urogynecologists: Highlights from the 29th Annual Meeting of the International Continence Society, the 2nd Annual Meeting of the International Children's Continence Society, and the 24th Annual Meeting of the International Urogynecology Association August 23-26, 1999, Denver. Rev Urol 2000 0.75
93 Should we be using chili pepper extracts to treat the overactive bladder? J Urol 1997 0.75
94 Stress urinary incontinence. Rev Urol 2000 0.75
95 Is nighttime voiding normal or anomalous? Rev Urol 2001 0.75
96 Complications associated with the use of vacuum constriction devices for erectile dysfunction in the spinal cord injured population. J Am Paraplegia Soc 1994 0.75
97 Should I do a pubovaginal sling operation on an obese woman? Rev Urol 2000 0.75
98 The role of renal scintigraphy in the evaluation of spinal cord injury patients with presumed urosepsis. J Urol 1996 0.75
99 Fine-needle aspiration of a periurethral Teflon-filled cyst following radical prostatectomy. Diagn Cytopathol 1992 0.75
100 Total incontinence secondary to sphincter destruction after prostate cryotherapy for recurrent prostatic carcinoma. Int J Urol 1996 0.75
101 Inguinal cystoceles: a previously overlooked etiology of prostatism in men without bladder outlet obstruction. J Urol 1998 0.75
102 Effects of atropine, glucagon, and bethanechol on urodynamics of continent cecal urinary reservoir before and after complete, partial, and sham detubularizations in dog. Neurourol Urodyn 1993 0.75
103 Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation. Int Urogynecol J Pelvic Floor Dysfunct 2002 0.75
104 Gene therapy and tissue engineering for urologic dysfunction: status and prospects. Mol Urol 2001 0.75
105 The role of yohimbine for the treatment of erectile impotence. J Sex Marital Ther 1990 0.75
106 Endoluminal ultrasonographic and histologic evaluation of periurethral collagen injection. J Endourol 1996 0.75
107 Transurethral placement of external sphincter wire mesh stent for neurogenic bladder. SCI Nurs 1994 0.75
108 Contact laser vaporization techniques for benign prostatic hyperplasia. J Endourol 1995 0.75
109 Mixed urinary incontinence secondary to lead poisoning. J Urol 1996 0.75
110 Simplified and objective assessment of spermatogenesis in spinal cord injured men by flow cytometry analysis. Paraplegia 1993 0.75
111 Transverse retubularized ileovesicostomy continent urinary diversion to the umbilicus. Tech Urol 2000 0.75
112 Metastatic osteomyelitis after pubovaginal sling using bone anchors. Urology 2000 0.75
113 Comparison of bladder rupture pressure after intestinal bladder augmentation (ileocystoplasty) and myomyotomy (autoaugmentation). Urology 1996 0.75
114 Feasibility of a temporary urethral stent through the striated sphincter in patients in the early phase (6 months) of spinal cord injury. Eur Urol 2001 0.75
115 Sutureless endoscopic colposuspension with fibrin sealant. Tech Urol 1995 0.75
116 Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder irritation. Urology 2001 0.75
117 In-vivo whole bladder response to anticholinergic and musculotropic agents in spinal cord injured rats. J Spinal Cord Med 1997 0.75
118 A urethral stent for the treatment of detrusor-striated sphincter dyssynergia. BJU Int 2000 0.75
119 Contact neodymium:yttrium-aluminum-garnet laser ablation of the external sphincter in spinal cord injured men with detrusor sphincter dyssynergia. Urology 1995 0.75
120 Spermatogenesis in early and chronic phases of experimental spinal cord injury in the rodent model. J Androl 1999 0.75
121 Intravesical capsaicin therapy: a review. J Spinal Cord Med 1999 0.75